Výsledky vyhledávání - Padget, Michelle
- Zobrazuji výsledky 1 - 19 z 19
-
1
-
2
Direct and antibody-dependent cell-mediated cytotoxicity of head and neck squamous cell carcinoma cells by high-affinity natural killer cells Autor Friedman, Jay, Padget, Michelle, Lee, John, Schlom, Jeffrey, Hodge, James, Allen, Clint
Vydáno 2019Text -
3
Differential combination immunotherapy requirements for inflamed (warm) tumors versus T cell excluded (cool) tumors: engage, expand, enable, and evolve Autor Fabian, Kellsye P, Padget, Michelle R, Fujii, Rika, Schlom, Jeffrey, Hodge, James W
Vydáno 2021Text -
4
Cisplatin and Oxaliplatin Induce Similar Immunogenic Changes in Preclinical Models of Head and Neck Cancer Autor Park, So-Jin, Ye, Wenda, Xiao, Roy, Silvin, Christopher, Padget, Michelle, Hodge, James W., Waes, Carter Van, Schmitt, Nicole C.
Vydáno 2019Text -
5
Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies Autor Friedman, Jay, Morisada, Megan, Sun, Lillian, Moore, Ellen C., Padget, Michelle, Hodge, James W., Schlom, Jeffrey, Gameiro, Sofia R., Allen, Clint T.
Vydáno 2018Text -
6
Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune-Tumor Interactions: Engage, Expand, Enable Autor Fabian, Kellsye P., Malamas, Anthony S., Padget, Michelle R., Solocinski, Kristen, Wolfson, Benjamin, Fujii, Rika, Sater, Houssein Abdul, Schlom, Jeffrey, Hodge, James W.
Vydáno 2020Text -
7
Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition... Autor Fenerty, Kathleen E., Padget, Michelle, Wolfson, Benjamin, Gameiro, Sofia R., Su, Zhen, Lee, John H., Rabizadeh, Shahrooz, Soon-Shiong, Patrick, Hodge, James W.
Vydáno 2018Text -
8
Correction to: Immunotherapy Utilizing the Combination of Natural Killer– and Antibody Dependent Cellular Cytotoxicity (ADCC)–Mediating Agents with Poly (ADP-ribose) polymerase (PA... Autor Fenerty, Kathleen E., Padget, Michelle, Wolfson, Benjamin, Gameiro, Sofia R., Su, Zhen, Lee, John H., Rabizadeh, Shahrooz, Soon-Shiong, Patrick, Hodge, James W.
Vydáno 2019Text -
9
Combinatorial Natural Killer Cell–based Immunotherapy Approaches Selectively Target Chordoma Cancer Stem Cells Autor Hoke, Austin T.K., Padget, Michelle R., Fabian, Kellsye P., Nandal, Anjali, Gallia, Gary L., Bilusic, Marijo, Soon-Shiong, Patrick, Hodge, James W., London, Nyall R.
Vydáno 2021Text -
10
Overcoming hypoxia-induced functional suppression of NK cells Autor Solocinski, Kristen, Padget, Michelle R, Fabian, Kellsye P, Wolfson, Benjamin, Cecchi, Fabiola, Hembrough, Todd, Benz, Stephen C, Rabizadeh, Shahrooz, Soon-Shiong, Patrick, Schlom, Jeffrey, Hodge, James W
Vydáno 2020Text -
11
PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations Autor Fabian, Kellsye P, Padget, Michelle R, Donahue, Renee N., Solocinski, Kristen, Robbins, Yvette, Allen, Clint T., Lee, John H., Rabizadeh, Shahrooz, Soon-Shiong, Patrick, Schlom, Jeffrey, Hodge, James W
Vydáno 2020Text -
12
Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells Autor Lee, Maxwell Y, Robbins, Yvette, Sievers, Cem, Friedman, Jay, Abdul Sater, Houssein, Clavijo, Paul E, Judd, Nancy, Tsong, Edward, Silvin, Chris, Soon-Shiong, Patrick, Padget, Michelle R, Schlom, Jeffrey, Hodge, James, Hinrichs, Christian, Allen, Clint
Vydáno 2021Text -
13
Stability of patient-specific features of altered DNA replication timing in xenografts of primary human acute lymphoblastic leukemia Autor Sasaki, Takayo, Rivera-Mulia, Juan Carlos, Vera, Daniel, Zimmerman, Jared, Das, Sunny, Padget, Michelle, Nakamichi, Naoto, Chang, Bill H., Tyner, Jeff, Druker, Brian J., Weng, Andrew P., Civin, Curt I., Eaves, Connie J., Gilbert, David M.
Vydáno 2017Text -
14
Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells Autor Robbins, Yvette, Greene, Sarah, Friedman, Jay, Clavijo, Paul E, Van Waes, Carter, Fabian, Kellsye P, Padget, Michelle R, Abdul Sater, Houssein, Lee, John H, Soon-Shiong, Patrick, Gulley, James, Schlom, Jeffrey, Hodge, James W, Allen, Clint T
Vydáno 2020Text -
15
An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele Autor Jochems, Caroline, Hodge, James W., Fantini, Massimo, Fujii, Rika, Maurice, Y. Morillon, Greiner, John W., Padget, Michelle R., Tritsch, Sarah R., Tsang, Kwong Yok, Campbell, Kerry S., Klingemann, Hans, Boissel, Laurent, Rabizadeh, Shahrooz, Soon-Shiong, Patrick, Schlom, Jeffrey
Vydáno 2016Text -
16
EXTH-63. EFFICIENT ADCC-MEDIATED KILLING OF MALIGNANT MENINGIOMA CELLS USING AVELUMAB AND AN ENGINEERED HIGH AVIDITY NATURAL KILLER CELL LINE, haNK Autor Giles, Amber, Hao, Shuyu, Fuji, Rika, Padget, Michelle, Song, Hua, Zhang, Wei, Cao, Xiaoyu, Jung, Jinkyu, Liu, Yang, Jensen, Randy, Lee, John, Shiong, Patrick Soon, Gillespie, David, Schlom, Jeffrey, Gilbert, Mark, Yang, Chunzhang, Hodge, James, Park, Deric
Vydáno 2018Text -
17
Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile Autor Cramer-Morales, Kimberly, Nieborowska-Skorska, Margaret, Scheibner, Kara, Padget, Michelle, Irvine, David A., Sliwinski, Tomasz, Haas, Kimberly, Lee, Jaewoong, Geng, Huimin, Roy, Darshan, Slupianek, Artur, Rassool, Feyruz V., Wasik, Mariusz A., Childers, Wayne, Copland, Mhairi, Müschen, Markus, Civin, Curt I., Skorski, Tomasz
Vydáno 2013Text -
18
Combination of PARP inhibitor olaparib, and PD-L1 inhibitor durvalumab, in recurrent ovarian cancer: a proof-of-concept phase 2 study Autor Lampert, Erika J., Zimmer, Alexandra, Padget, Michelle, Cimino-Mathews, Ashley, Nair, Jayakumar, Liu, Yingmiao, Swisher, Elizabeth M., Hodge, James W., Nixon, Andrew B., Nichols, Erin, Bagheri, Mohammad H., Levy, Elliott, Radke, Marc R., Lipkowitz, Stanley, Annunziata, Christina M., Taube, Janis M., Steinberg, Seth M., Lee, Jung-Min
Vydáno 2020Text -
19
Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK Autor Giles, Amber J., Hao, Shuyu, Padget, Michelle, Song, Hua, Zhang, Wei, Lynes, John, Sanchez, Victoria, Liu, Yang, Jung, Jinkyu, Cao, Xiaoyu, Fujii, Rika, Jensen, Randy, Gillespie, David, Schlom, Jeffrey, Gilbert, Mark R., Nduom, Edjah K., Yang, Chunzhang, Lee, John H., Soon-Shiong, Patrick, Hodge, James W., Park, Deric M.
Vydáno 2019Text